Commonly used seizure drug could treat severe genetic liver disease

The liver scarring of ±1-antitrypsin (AT) deficiency, the most common genetic cause for which children undergo liver transplantation, might be reversed or prevented with a medication long used to treat seizures, according to researchers. Because the anti-seizure drug is familiar to doctors and has a well-understood safety profile, clinical trials could begin immediately to see whether it can help affected patients.

Read the whole article on Science Daily

More from Science Daily